![Biogen och Sobi medd](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Biogen och Sobi meddelar att den Europeiska läkemedelsmyndigheten validerat ansökan om marknadsföringstillstånd för Alprolix® (rFIXFc)
June 26, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Cambridge, Mass., USA och Stockholm, Sverige, 26 juni 2015 Biogen (NASDAQ: BIIB) och Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) meddelade idag att den europeiska läkemedelsmyndigheten...
![Sobi Board of Direct](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobi Board of Directors terminates discussions regarding non-binding proposal
June 08, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
On 27 April 2015 the Board of Swedish Orphan Biovitrum AB (publ) (Sobi) confirmed that it had received a preliminary and conditional non-binding proposal in relation to a possible offer for all...
![Sobis styrelse avslu](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobis styrelse avslutar samtal om icke-bindande förslag
June 08, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Den 27 april 2015 bekräftade Swedish Orphan Biovitrum ABs (publ) (Sobi) styrelse att man erhållit ett preliminärt och villkorat icke-bindande förslag avseende ett möjligt bud på bolagets samtliga...
![Sobis samarbetspartn](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobis samarbetspartner Biogen ansöker om marknadsgodkännande för Alprolix® (rFIXFc) i Europa
June 04, 2015 08:30 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) meddelade idag att samarbetspartnern Biogen lämnat in en ansökan till Europeiska läkemedelsmyndigheten EMA, om marknadsgodkännande förAlprolix (rFIXFc)....
![Sobi's partner Bioge](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobi's partner Biogen submits marketing authorisation application for Alprolix® (rFIXFc) in Europe
June 04, 2015 08:30 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) announced today that partner Biogen has submitted a Marketing Authorisation Application (MAA) for Alprolix (rFIXFc) to the European Medicines Agency...
![Kallelse till årsstä](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)
May 27, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Aktieägarna i Swedish Orphan Biovitrum AB (publ), org. nr 556038-9321, kallas härmed till årsstämma tisdagen den 30 juni 2015 kl. 14.00 i Wallenbergsalen på Kungliga Ingenjörsvetenskapsakademien...
![Notice of annual gen](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
May 27, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
The shareholders in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, are hereby summoned to the annual general meeting (the "Meeting"), to be held on Tuesday 30 June 2015 at 2.00 p.m. in...
![Sobi publishes its R](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobi publishes its Report for the First Quarter 2015
May 06, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the first quarter 2015. Revenues for the quarter totalled SEK 865 M (573). All parts of the business contributed to the...
![Sobi publicerar sin](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobi publicerar sin rapport för första kvartalet 2015
May 06, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) presenterade idag sitt resultat för första kvartalet 2015. Intäkterna för kvartalet uppgick till totalt SEK 865 M (573). Alla delar av portföljen bidrog...
![Sobi's Board of Dire](/news-release/logo/357034/0/357034.jpg?lastModified=12%2F09%2F2016%2023%3A00%3A59&size=2)
Sobi's Board of Directors postpones Annual General Meeting of Shareholders
April 29, 2015 02:05 ET
|
Swedish Orphan Biovitrum AB
On 27 April 2015 the Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi) confirmed that it had received a preliminary and conditional non-binding proposal in relation to a possible...